-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Hold on Beta Bionics, Raises Price Target to $21

Benzinga·10/28/2026 16:41:47
Listen to the news
TD Cowen analyst Mathew Blackman maintains Beta Bionics (NASDAQ:BBNX) with a Hold and raises the price target from $18 to $21.